Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Quantitative Computed Tomography and Magnetic Resonance Assessment of Vascular Compression in the Thoracic Outlet.

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery·2025

Same author

Systematic Review on Botulinum Toxin Injections as Diagnostic or Therapeutic Tool in Thoracic Outlet Syndrome.

Annals of vascular surgery·2023

Same author

Re: "Medium Term Outcomes of Deep Venous Stenting in the Management of Venous Thoracic Outlet Syndrome".

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery·2023

Same author

Thoracic outlet syndrome (TROTS) registry: A study protocol for the primary upper extremity deep venous thrombosis section.

PloS one·2023

Same author

Synthetic MRI with Magnetic Resonance Spin TomogrAphy in Time-Domain (MR-STAT): Results from a Prospective Cross-Sectional Clinical Trial.

Journal of magnetic resonance imaging : JMRI·2022

Same author

The profile of cognitive impairment and hemodynamic compromise in moyamoya: a single-center prospective cohort study.

Journal of neurosurgery·2022

Same journal

Modeling and analysis of forward and inverse kinematics for a flexible Stewart platform.

PloS one·2026

Same journal

Barriers and facilitators to healthcare utilization amongst people living with sickle cell disease in the United States: A scoping review.

PloS one·2026

Same journal

Enhancing data completeness in time series: Imputation strategies for missing data using significant periodically correlated components.

PloS one·2026

Same journal

Key targets and mechanisms by which gut microbiota-derived metabolites regulate Alzheimer's disease through the immune - inflammatory pathway: Based on network pharmacology and molecular docking.

PloS one·2026

Same journal

Grid-tied Transformer-less Boost Switched Capacitor Topology (TLBSCT) for PV applications.

PloS one·2026

Same journal

The load-velocity profiles and exercise-specific velocity zones for seven commonly used weightlifting exercises.

PloS one·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Mar 15, 2026

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

Renal Denervation in a Real Life Setting: A Gradual Decrease in Home Blood Pressure.

Martine M A Beeftink¹, Wilko Spiering², Michiel L Bots³

¹Department of Cardiology, University Medical Center Utrecht, Utrecht, the Netherlands.

|September 16, 2016

Summary

This summary is machine-generated.

Renal denervation gradually lowers blood pressure over 12 months, with home blood pressure monitoring proving effective for tracking these changes. This study highlights a sustained reduction in hypertension post-procedure.

More Related Videos

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension

Published on: June 6, 2025

Novel Approach for Simultaneous Recording of Renal Sympathetic Nerve Activity and Blood Pressure with Intravenous Infusion in Conscious, Unrestrained Mice.

Novel Approach for Simultaneous Recording of Renal Sympathetic Nerve Activity and Blood Pressure with Intravenous Infusion in Conscious, Unrestrained Mice.

Published on: February 14, 2018

Related Experiment Videos

Last Updated: Mar 15, 2026

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension

Published on: June 6, 2025

Novel Approach for Simultaneous Recording of Renal Sympathetic Nerve Activity and Blood Pressure with Intravenous Infusion in Conscious, Unrestrained Mice.

Novel Approach for Simultaneous Recording of Renal Sympathetic Nerve Activity and Blood Pressure with Intravenous Infusion in Conscious, Unrestrained Mice.

Published on: February 14, 2018

Area of Science:

Cardiovascular medicine
Nephrology
Hypertension management

Background:

Renal denervation is an emerging therapy for resistant hypertension.
Understanding long-term blood pressure dynamics post-procedure is crucial for clinical practice.

Purpose of the Study:

To assess blood pressure changes over 12 months following renal denervation.
To evaluate the utility of home blood pressure monitoring in this context.

Main Methods:

A cohort of 70 patients underwent standardized monthly home blood pressure monitoring for one year post-renal denervation.
Office and 24-hour ambulatory blood pressure monitoring were conducted at baseline and 12 months.

Main Results:

A gradual decrease in home systolic blood pressure (0.53 mmHg/month) and diastolic blood pressure (0.26 mmHg/month) was observed.
Significant average reductions were noted: 8.1 mmHg systolic (home), 9.3 mmHg (ambulatory), and 15.9 mmHg (office) at 12 months.
Antihypertensive medication use remained stable throughout the study period.

Conclusions:

Renal denervation leads to a sustained, gradual reduction in blood pressure up to one year post-procedure.
Home blood pressure monitoring is a viable alternative to ambulatory monitoring for assessing outcomes after renal denervation.